Search

Your search keyword '"Non-small cell lung cancer -- Reports -- Forecasts and trends"' showing total 20 results
Start Over Descriptor "Non-small cell lung cancer -- Reports -- Forecasts and trends" Topic general interest
20 results on '"Non-small cell lung cancer -- Reports -- Forecasts and trends"'

1. Global PD-L1 NSCLC Market: Insights, Epidemiology, Drugs and Players (2017-2030)

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

2. Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights and Forecasts, 2017-2030

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

3. ALK Non-Small Cell Lung Cancer Markets, Forecast to 2030 - Market Analysis, Pipeline, Epidemiology, Drug Sales & Shares by Country and Competition

Subjects
Drugs -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has [...]

Published
2020

4. Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC) Markets to 2030

Subjects
Brigatinib -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Crizotinib -- Reports -- Forecasts and trends, Ceritinib -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Anaplastic Lymphoma Kinase Non-Small Cell Lung Cancer (ALK-NSCLC)- Market Insights, Epidemiology and Market Forecast to 2030' drug pipelines has [...]

Published
2020

5. Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030

Subjects
Cabozantinib -- Reports -- Forecasts and trends, Canakinumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Stem cells -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, German foreign relations, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - [...]

Published
2020

6. BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2030' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2020

7. Global Tissue Diagnostics Market (2020 to 2025) - Growing Demand for Personalized Medicines Presents Opportunities

Subjects
Precision medicine -- Forecasts and trends -- Reports, Cancer screening -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Biological products -- Supply and demand, Breast cancer, Cancer diagnosis, Cancer research, End users, Cancer, Tumors, Diseases, Medium term notes, Antibodies, Technology, Hospitals, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following news release: The 'Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease [...]

Published
2020

8. Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Stem cells, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: -The 'Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030' report has been added [...]

Published
2020

9. Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidermal growth factors -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC) - Epidemiology Forecast to 2030' report has been added to [...]

Published
2020

10. Global Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer Market - Epidemiology Forecast to 2030

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lymphomas -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Non-Hodgkin's lymphomas, Tumors, Lung cancer, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Anaplastic Lymphoma Kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030' report has been added to [...]

Published
2020

11. Insights into the Worldwide BRAF Mutated Non-Small Cell Lung Cancer (2018 to 2030) - Organize Sales and Marketing Efforts by Identifying the Best Opportunities

Subjects
Dabrafenib -- Reports -- Forecasts and trends, Marketing -- Forecasts and trends -- Reports, Small cell lung cancer -- Forecasts and trends -- Reports, Trametinib -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'BRAF Mutated Non-Small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

12. Non-Small Cell Lung Cancer (NSCLC) Market Forecasts to 2030: A Comprehensive Insight

Subjects
Small cell lung cancer -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to [...]

Published
2020

13. Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Monoclonal antibodies -- Reports -- Forecasts and trends, Trametinib -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Dabrafenib -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Avelumab, Necitumumab, Larotrectinib, Atezolizumab, Dacomitinib, Lorlatinib, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports, Tagrisso (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to [...]

Published
2020

14. Global Lung Cancer Therapeutics Market Study, 2019-2025

Subjects
Cancer research -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Displays (Marketing), Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Lung Cancer Therapeutics - Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. The Lung Cancer [...]

Published
2019

15. Global Immune Checkpoint Inhibitors Market Outlook 2022: NSCLC & Melanoma Showing Greatest Contributions to the IO Market

Subjects
Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Reports -- Forecasts and trends, Atezolizumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Avelumab -- Reports -- Forecasts and trends, Immunotherapy -- Reports -- Forecasts and trends, Pembrolizumab -- Reports -- Forecasts and trends, Melanoma -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Tumors, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Global Immune Checkpoint Inhibitors Market Outlook 2022' report has been added to ResearchAndMarkets.com's offering. The global immune checkpoint inhibitors [...]

Published
2019

16. Global Non-Small Cell Lung Cancer Market and Competitive Landscape Report 2018 - ResearchAndMarkets.com

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN:Research and Markets has issued the following press release: -The 'Global Non-Small Cell Lung Cancer Market and Competitive Landscape - 2018' report has been added to ResearchAndMarkets.com's offering. Global Non-Small [...]

Published
2018

17. Non-Small Cell Lung Cancer Therapeutics Market Share by Manufacturers, by Regions, by Application

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Company market share, Market trend/market analysis, General interest
Abstract

India, Oct. 5 -- size:12.0ptLung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness [...]

Published
2018

18. Non-Small Cell Lung Cancer Therapeutics Market Share by Manufacturers, by Regions, by Application

Subjects
Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Company market share, Market trend/market analysis, General interest
Abstract

India, Oct. 5 -- size:12.0pt'>Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness [...]

Published
2018

19. ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model

Subjects
Diagnostic reagents -- Reports -- Forecasts and trends, Medical testing products -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Small cell lung cancer, Accounting, Cancer, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York: ReportLinker FR has issued the following press release: Reportlinker.com announces the release of the report 'ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model' - [...]

Published
2018

20. Non-Small Cell Lung Cancer Market to 2020: Radiant Insights

Subjects
Business information services -- Reports -- Forecasts and trends, Small cell lung cancer -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Business database, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Nov 13, 2015 (M2 PRESSWIRE via COMTEX) -- Summary Radiant Insights, a leading business intelligence provider, has released its latest research report, 'Non-Small Cell Lung Cancer Market to 2020 - [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results